Pioglitazone - Latest Advances

Anticancer and apoptotic effect of alogliptin on A549 cancer cell line.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: April 09, 2026

Drug repurposing in the management of major depressive disorder: a perspective.

Journal: East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan

Published: March 31, 2026

Targeted Degradation of Dipeptidyl Peptidase-4 via Proteolysis-Targeting Chimera Technology for Sustained Glycemic Control in Type 2 Diabetes.

Journal: Journal of medicinal chemistry

Published: March 13, 2026

Computational discovery of precision therapeutics for hidradenitis suppurativa.

Journal: bioRxiv : the preprint server for biology

Published: March 09, 2026

Peroxisome Proliferator-Activated Receptors (PPARs) in Psoriasis: Metabolic Intersections, Molecular Mechanisms, and Potential Treatments.

Journal: Cureus

Published: March 02, 2026

A multimodal approach integrating spectroscopy, deep learning guided molecular docking, and molecular dynamics simulation for predictive assessment of pioglitazone to albumin binding for formulation development.

Journal: Analytical methods : advancing methods and applications

Published: February 25, 2026

Drug repurposing in Alzheimer's disease: Emerging therapeutic strategies and promising candidates.

Journal: Ageing research reviews

Published: February 24, 2026

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

Journal: JAMA network open

Published: February 23, 2026

Retraction of: Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.

Journal: The Journal of pharmacy and pharmacology

Published: February 09, 2026

Pioglitazone Attenuates Sepsis-Associated Acute Kidney Injury by Modulating TLR-4/NF-κB Signaling and Improving Survival and Renal Function.

Journal: Journal of clinical medicine

Published: January 30, 2026

Editorial: Exploiting non-oncogene addiction for overcoming drug resistance in metastatic tumors.

Journal: Frontiers in pharmacology

Published: January 28, 2026

Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: January 25, 2026